Up on 137K shares the day before report. I believe the SST deal is VERY good. Not so much for immediate income but SST is a major player in back end structure/ cloud / digital Ag.
In major report to the Iowa AgState Group
THE DIGITAL TRANSFORMATION
OF ROW CROP AGRICULTURE:
"The Leaders in the segment are John Deere & Co, DuPont Pioneer, Monsanto/The Climate Corp., SST Software, and WinField / Land O’Lakes.
The report says, SST platforms "help overcome the issue of lack of standards in the industry, incompatibility, and fragmentation of the services provided to farmers."
The report calls for creation of "an independent, farmer-controlled data warehouse for farm level data
and aggregated agronomic data which can be used to better serve farmer participants"
The vision is to create "A FARMER-CENTRIC STRATEGY
What will "drive" that vision is:
"the establishment of a cloud based data warehouse for farmers that is coordinated with ag retailers.
"Potential options include SST and Amazon Web Services."
SST had over 82 Million acres under management at the time of the report. So it seems Clearag is locking itself into a major player. and it will be interesting to hear comments in CC on this major step forward.
Click corporate, click investor center, scroll almost to the bottom, click Company PowerPoint.
I think they are mentioning the capture of 15 to 30% of the market for proton. Aren't they? If that could happen the company is going to be inking a lot of deals.
They had a golden era for signing Gammas. 4 in one year. That market matured. If they are going into the golden years for proton, it's something to think about. It's a whole new era. Possibly it will dwarf the years of dividend and $6 a share.
It's a new value proposition and there's just no comparison to 15% of Gamma market.
Of course it would take many years but it's really a whole untapped market replacing a tapped out market. The company might be valued more favorably if they can show that they have a chance to grab 15%.
I'm googling around and see there is a competitor in Providence Proton Therapy. This means a company was started to do what ASHS is doing and provide off balance sheet way of using a proton. That means there's a market opportunity. ASHS is in a good competitive situation, I would think.They already have one up and running.
There should be more insider buys.
This is happening on volume and ahead of ER, just before the last two presentations were without the CEO being there.
I'm wondering the cause of pullback and how far it might go. Checking the 5 and even 10 year chart it looks like price and 50DMA often gets a little too far ahead of 200 DMA but the overall trend is up. Big bounce coming soon enough, imo.
At some point I'll get greedy. May call IR first. Look at insider activity. A year ago the prices paid were up to $2.20:
Sep 4, 2015 SCHMIDT ANDREW C
10,000 Direct Purchase at $2.20 - $2.2 per share. 22,0002
Aug 26, 2015 DALY KEVIN
10,000 Indirect Purchase at $2.09 - $2.09 per share. 21,0002
Aug 25, 2015 DALY KEVIN
5,000 Indirect Purchase at $2.05 - $2.05 per share. 10,0002
Aug 24, 2015 MINER GREG
10,000 Direct Purchase at $2.05 - $2.05 per share. 21,0002
Aug 24, 2015 DALY KEVIN
5,200 Indirect Purchase at $2.05 - $2.08 per share. 11,0002
Aug 20, 2015 DALY KEVIN
23,600 Indirect Purchase at $2.02 - $2.09 per share. 48,0002
Aug 20, 2015 THOMAS TOM
15,000 Direct Purchase at $2.05 - $2.05 per share. 31,0002
Aug 19, 2015 DALY KEVIN
4,300 Indirect Purchase at $2 - $2 per share. 8,6002
Aug 18, 2015 DALY KEVIN
10,000 Indirect Purchase at $2.01 - $2.01 per share. 20,0002
Aug 18, 2015 MINER GREG
10,000 Direct Purchase at $2 - $2 per share. 20,0002
Aug 14, 2015 MINER GREG
Deal momentum is about to swell. ClearAg is going EBITDA positive in time and will be a big driver of value. Checking siteworthtraffic, clearAg is gathering a LOT of steam as far as unique visitors to the site goes (93, triple from when I first checked a short while ago). They don't show the app statistics but say that feature is coming soon.
It was 1000@$2.04 bought on 6-06 and 500 @ $2.08 bought on 6-8. $3079 is not very much but nice to see. What about other executives and board members? Maybe there will be another round of buying ahead of the investor presentation.
I noticed an island bottom completed 6-4. That hopefully ends the pullback from over $2.50.
"The Island Bottom occurs when the price "gaps" below a specific price range for a number of days and then is confirmed when the price "gaps" above the original range."
Any more insider buys would be appreciated. The rounded bottom is "in". The island bottom looks promising. Golden cross looks good too. Just need to seal it in with a bit more buying.
Then we should get the investor presentation along with 8 straight Qs of decent results due to ramp of Orlando. Another site or two PR's and it should be a thing of beauty.
A few twists and turns but on it's way to better things. Thank you Mr. Nurthern for winning that award. Many drivers of value mentioned in the call. Bigger markets, bigger head counts better products and platforms, more EBITDA more cash Flow, some untapped relationships Mckesson, Toro, CDK etc. Churn and margins being addressed.
I posted a reply to the streetsweeper rebuff article posted by Cliffside at seeking Alpha. Spent a little time on it. My 2 cents.
Could be significant once it's in full gear. SST: "Today, our system manages site-specific data for over 100 million acres spanning 23 countries."
Maybe clearAg can eventually plug into SST's existing ecosystem with the full array of clearAg products.
SST has some interesting Vids posted. I notice right after this announcement a surge in unique visitors to clearag. Recently the rate has grown by 20,000 or so per year. Very interesting pick up in visitors.
Whenever anyone recommends a stock you should check their site to see what the disclosures are. I think there are laws that require disclosure. You can have a bad article written against MITK and then short the stock. There is no legal recourse anyone can take if you comply fully with the law and openly tell them of your self interest.
I think the law allows you to make money off anyone who fails to read the disclosure and who is unaware of your blatant self interest.
In defense of this law it allows people to express their ideas about a stock and not fear being sued.
I read the article and the disclosure and bought more MITK because I like their business model, which is to leverage the relationship they have via the core competencies MITK has in MD and design more products and more importantly buy companies with patents on products that the banks want and fit with MITK's competencies.
I think there is a long runway and the stock could go up a hundred times over the years and decades.
What MITK has and will always have over the next 20 years is the relationship with banks as provider of high roi banking saas software. MD will make a few millions but the relationship with all these banks will make a lot more millions over the decades.
Relationships are both their moat and their competitive advantage. You don't have to have the best product but a good one that banks want and a direct channel to the banks--thanks to MD success, they now have a direct channel to the FIs. I believe their patents are super solid BTW.
MITK always goes higher than anyone imagines and sells of lower than anyone imagines but in my estimation the business model should drive value and PPS long term.
Read 100 baggers, $8.99 if you have a Kindle.
Regarding insider selling, CFO Russell Clark says Thornton's sales were done for estate planning purposes, that DeBello's are part of a structured selling plan, and that his were done to help pay for his kids' college expenses. He insists Mitek has no remaining IP issues, and defended the strength of its patent portfolio (features 26 patents, along with others in the pipeline).
So, altogether, we think Mitek stock will bobble and stumble by about 50 percent in the near-term. Even then the company would be unlikely to justify such a high valuation.
* Important Disclosure: The owners of TheStreetSweeper hold a short position in MITK and stand to profit on any future declines in the stock price.
THE STREET SWEEPER'S OWNERS DO HOLD STOCKS IN COMPANIES THAT ARE REVIEWED ON THIS WEBSITE and will regularly take long or short positions in the securities of any publicly traded company at any time before or after the company is the subject of, or otherwise discussed or referred to in articles or other writing on our website. When THE STREET SWEEPER OWNERS have an interest in securities discussed in investigative articles on the website, we will disclose this AT THE BOTTOM OF EACH ARTICLE. We will not knowingly omit this disclosure in any of our stories.
THESE POSITIONS WILL AFFECT OUR OBJECTIVITY. Each investor must make his or her own decisions based on independent research and their judgment of the market as well as consultation with a qualified licensed investment professional.
The best asset MITK has is it's relationship with banks via MD. They can buy companies that have the patented products these banks want. That's what MITK is doing. Leveraging the locked in relationships. It's a business model that could be sustainable for years. There's a long runway in ID.
siteworthtraffic just reported page views at clearag shot up to 211 after having plateaued at 126 views daily. Don't know how good that is or if it will fall back down but it sure sounds good. A little while ago it was 36 page views a day.
Fantastic!! If there was ever a messenger that needed to be shot and got shot it's lyin' streetsweeper.
Wow! MITK is "addressing a different problem, onboarding new mobile accounts".
So it appears to be a bold faced lie to insinuate there is any problem for MITK. Nice find!
Possibly 24 more deals to come. The runway is long. If this strategy works the recurring high margin revenues could slowly ramp for years and years. They seem to think it will work, so we'll see.
Mitek CFO Clark Says Ancient History Dredged Up When StreetSweeper Brought Up IP, Says Continues To Build Strong IP Moat With 26 Patents And More Coming Through The Pipeline
Just had a seeking alpha article in April questioning the patents. Here's another one questioning patents and here's yet another buying opportunity.
The company is growing high margin top line at near 40%; hence the high multiple.
Look at 2014 top line and compare it to 2015. The added revenue was good but what's better is, it went directly into operating profits. This is high quality growth. It's recurring revenue streams by highly sticky customers and it creates value for all shareholders as long as it goes on. Hence the $9.75 target . As long as MITK executes another target will be set---higher
IMO, It's just the first step towards a vicious short covering rally in the making.
When you look at book value, it's hard to make a case for overvaluation.
Just my two cents: If the company can make convincing investor presentations, firmly tying a solid ASHS to the exciting, momentum in Proton, it should be compelling. Just the mention of the words "tipping point", a few graphs and bragging rights to Orlando success could get some attention.
Breaking news: A highly respected journal just printed a special edition on Proton. Must read 5-25 article mentions "tipping point": Google, "Proton Therapy Opens Unique Window on Cancer Research".
I feel the main thing we have to watch is if the ClearAg strategy as a whole seems to be on track. If it's on track and the rest of the business remains solid--well we have nothing to worry about; it's just a matter of time before the stock really responds and the investment community gets wind of it all.
Judging by the presentation I have no qualms at all. I'm a happy holder. I wonder where the CEO is but am I worried? Absolutely not. They happen to have a tremendous bench anyway.
Check Glassdoor-- you should read the comments. CEO has 80% approval. People seem to think the company is doing very well. I tend to agree. It may be coming inflection point. Higher margins, recurring SaaS revs possibly coming. Zero debt in a possible raising interest rate environment is also a plus.
It will take time though.This is a 2017-2018 story.
...according to presentation. They seem to be growing in confidence that it will grow to scale and ClearAg will be a really serious value driver for Iteris. No mention of CEO, Bergera but really good presentation by Mr Daley and CFO. Expect 2 -3 major, "Bayer - like" deals over next 12 Months.